JAC-Antimicrobial Resistance

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
JAC-Antimicrobial Resistance - Tập 3 Số 4 - 2021
Renato Pascale, Zeno Pasquini, Michele Bartoletti, Luca Caiazzo, Giacomo Fornaro, Linda Bussini, Francesca Volpato, Elisa Marchionni, Matteo Rinaldi, Filippo Trapani, Chiara Temperoni, Paolo Gaibani, Simone Ambretti, Francesco Barchiesi, Pierluigi Viale, Maddalena Giannella
Abstract Objectives To analyse the impact of cefiderocol use on outcome in patients admitted to the ICU for severe COVID-19 and further diagnosed with carbapenem-resistant Acinetobacter baumannii (CR-Ab) infection. Methods Retrospective multicentre observational study was performed at four Italian hospitals, from January 2020 to April 2021. Adult patients admitted to ICU for severe COVID-19 and fu... hiện toàn bộ
In vitroactivity of the siderophore cephalosporin, cefiderocol, against molecularly characterized, carbapenem-non-susceptible Gram-negative bacteria from Europe
JAC-Antimicrobial Resistance - Tập 2 Số 3 - 2020
Christopher Longshaw, Davide Manissero, Masakatsu Tsuji, Roger Echols, Yoshinori Yamano
AbstractObjectivesMany carbapenem-resistant (CR) Gram-negative (GN) pathogens exhibit MDR, meaning few therapeutic options are available for CR-GN infections. Cefiderocol, a siderophore cephalosporin, has demonstrated in vitro efficacy against CR-GN bacteria. In the SIDERO-CR-2014–2016 surveillance study, European clinical isolates comprising carbapenem-non-susceptible (CarbNS) Enterobacterales an... hiện toàn bộ
Antimicrobial stewardship programmes in health-care facilities in low- and middle-income countries: a WHO practical toolkit
JAC-Antimicrobial Resistance - Tập 1 Số 3 - 2019
Tổng số: 3   
  • 1